Bide Pharmatech Co. Ltd. A Cash Flow-to-Debt Ratio
Bide Pharmatech Co. Ltd. A cash flow-to-debt ratio. Bide Pharmatech Co. Ltd. A (688073) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2025, meaning its operating cash flow of CN¥28.32 Million could theoretically repay 0% of its total liabilities (CN¥471.40 Million) in one year. Check 688073 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bide Pharmatech Co. Ltd. A (2020–2025)
Cash flow-to-debt ratio of Bide Pharmatech Co. Ltd. A from 2020 to 2025. Historical debt coverage capacity for Bide Pharmatech Co. Ltd. A across 6 annual periods. Check Bide Pharmatech Co. Ltd. A cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Bide Pharmatech Co. Ltd. A Cash Flow-to-Debt Ratio by Year (2020–2025)
Bide Pharmatech Co. Ltd. A cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for Bide Pharmatech Co. Ltd. A. For the full cash flow conversion analysis, see Bide Pharmatech Co. Ltd. A operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | CN¥28.32 Million | CN¥471.40 Million | ▼ -85.2% |
| 2024 | 0.40x | CN¥158.31 Million | CN¥390.91 Million | ▲ +329.7% |
| 2023 | -0.18x | CN¥-57.39 Million | CN¥325.49 Million | ▼ -267.1% |
| 2022 | 0.11x | CN¥29.87 Million | CN¥283.05 Million | ▲ +145.1% |
| 2021 | -0.23x | CN¥-64.88 Million | CN¥277.27 Million | ▼ -1176.2% |
| 2020 | 0.02x | CN¥3.65 Million | CN¥167.64 Million | — |